Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-28T10:00:31.906Z Has data issue: false hasContentIssue false
  • English
  • Français

Etiology of Fever and Opportunities for Reduction of Antibiotic Use in a Pediatric Intensive Care Unit

Published online by Cambridge University Press:  02 January 2015

Philip Toltzis ,
Bonnie Rosolowski  and
Ann Salvator
Philip Toltzis*
Affiliation:
Department of Pediatrics, Case Western Reserve University School of Medicine, and Rainbow Babies and Children's Hospital of the University Hospitals of Cleveland, Cleveland, Ohio
Bonnie Rosolowski
Affiliation:
Department of Pediatrics, Case Western Reserve University School of Medicine, and Rainbow Babies and Children's Hospital of the University Hospitals of Cleveland, Cleveland, Ohio
Ann Salvator
Affiliation:
Department of Pediatrics, Case Western Reserve University School of Medicine, and Rainbow Babies and Children's Hospital of the University Hospitals of Cleveland, Cleveland, Ohio
*
Rainbow Babies and Children's Hospital, 11100 Euclid Ave, Cleveland, OH 44106
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To determine the cause of fever in critically ill children and to identify opportunities for reducing antibiotic use in this population.

Design:

Prospective case series.

Setting:

A tertiary-care medical-surgical pediatric intensive care unit (PICU).

Patients:

Children admitted to the PICU who experienced fever (axillary temperature >38.3°C).

Measurements:

Consecutive children who were febrile at any point in their PICU stay were investigated over two winter seasons. Etiology of the fever was determined by physical examination and routine microbiology and radiographic tests. Three subgroups were reviewed to approximate the number of antibiotic-days that could have been reduced; namely, those with an indeterminate source, those with a documented viral infection, and those receiving a prolonged course of antibiotics. A set of standards reflecting common antibiotic use then was applied to these three patient groups.

Results:

Of 211 subjects, the majority (83.3%) had either a definitive or suspected focus for their fever, and nearly all of these patients were judged to have an infectious etiology. The study population received a total of 2,036 antibiotic-days. Despite the high incidence of infectious causes of fever in our subjects, however, approximately 15% of total antibiotic-days could have been reduced by applying common-use standards.

Conclusions:

Fever in the PICU was usually of defined focus and infectious in origin. However, among febrile patients in the PICU, substantial opportunity exists for reduction of antibiotic use. Trials determining the safety of antibiotic reduction in this population should be pursued vigorously.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 22 , Issue 8 , August 2001 , pp. 499 - 504
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Cunha, BA. Antibiotic resistance: control strategies. Crit Care Clin 1998;14:309–327.CrossRefGoogle ScholarPubMed
2. Gaynes, R. The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals. Infect Dis Clin North Am 1997;11:757–765.CrossRefGoogle ScholarPubMed
3. Goldmann, DA, Weinstein, RA, Wenzel, RP, Tablan, OC, Duma, RJ, Gaynes, RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA 1996;275:234–240.Google Scholar
4. Gould, IM. A review of the role of antibiotic policies in the control of antibiotic resistance. J Antimicrob Chemother 1999;43:459–465.Google Scholar
5. McGowan, JE Jr, Tenover, FC. Control of antimicrobial resistance in the health care system. Infect Dis Clin North Am 1997;11:297–311.CrossRefGoogle ScholarPubMed
6. Shlaes, DM, Gerding, DN, John, JF Jr, Craig, WA, Bornstein, DL, Duncan, RA et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997;18:275–291.CrossRefGoogle Scholar
7. Tenover, FC, McGowan, JE Jr. Reasons for the emergence of antibiotic resistance. Am J Med Sci 1996;311:9–16.Google Scholar
8. Burwen, DR, Banerjee, SN, Gaynes, RE. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States: National Nosocomial Infection Surveillance System. J Infect Dis 1994;170:1622–1625.Google Scholar
9. Archibald, L, Phillips, L, Monnet, D, McGowan, JE Jr, Tenover, F, Gaynes, R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997;24:211–215.CrossRefGoogle ScholarPubMed
10. Itokazu, GS, Quinn, JP, Bell-Dixon, C, Kahan, FM, Weinstein, RA. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis 1996;23:779–784.Google Scholar
11. D'Agata, EM, Venkataraman, L, DeGirolami, P, Burke, P, Eliopoulos, GM, Karchmer, AW, et al. Colonization vrith broad-spectrum cephalosporin-resistant gram-negative bacilli in intensive care units during a nonout-break period: prevalence, risk factors, and rate of infection. Crit Care Med 1999;27:1090–1095.CrossRefGoogle ScholarPubMed
12. Flaherty, JP, Weinstein, RA. Nosocomial infection caused by antibiotic-resistant organisms in the intensive-care unit. Infect Control Hosp Epidemiol 1996;17:236–248.CrossRefGoogle ScholarPubMed
13. Jarlier, V, Fosse, T, Philippon, A. Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study). Intensive Care Med 1996;22:1057–1065.Google Scholar
14. Cunha, BA. Fever in the critical care unit. Crit Care Clin 1998;14:1–14.Google Scholar
15. O'Grady, NP, Bade, PS, Bartlett, JG, Bleck, T, Garvey, G, Jacobi, J, et al. Practice guidelines for evaluating new fever in critically ill adult patients: Task Force of the Society of Critical Care Medicine and the Infectious Diseases Society of America. Clin Infect Dis 1998;26:1042–1059.CrossRefGoogle Scholar
16. Toltzis, P, Yamashita, T, Vilt, L, Blumer, JL. Colonization with antibiotic-resistant gram-negative organisms in a pediatric intensive care unit. Crit Care Med 1997;25:538–544.Google Scholar
17. Pizzo, PA, Robichaud, KJ, Gill, FA, Witebsky, FG, Levine, AS, Deisseroth, AB, et al. Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med 1979;67:194–200.Google Scholar
18. Davies, RJ, Gleeson, FV. The diagnosis and management of pleural empyema. Curr Opin Pulm Med 1998;4:185–190.Google Scholar
19. Heffner, JE. Infection of the pleural space. Clin Chest Med 1999;20:607–622.Google Scholar
20. Cunha, BA, Gill, MV, Lazar, JM. Acute infective endocarditis: diagnostic and therapeutic approach. Infect Dis Clin North Am 1996;10:811–834.Google Scholar
21. Hoesley, CJ, Cobbs, CG. Endocarditis at the millennium. J Infect Dis 1999;179(suppl 2):S360–S365.CrossRefGoogle ScholarPubMed
22. Ramsey, BW. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med 1996;335:179–188.CrossRefGoogle ScholarPubMed
23. Circiumaru, B, Baldock, G, Cohen, J. A prospective study of fever in the intensive care unit. Intensive Care Med 1999;25:668–673.Google Scholar
24. McGowan, KL, Foster, JA, Coffih, SE. Outpatient pediatric blood cultures: time to positivity. Pediatrics 2000;106:251–255.CrossRefGoogle ScholarPubMed
25. Garcia-Prats, JA, Cooper, TR, Schneider, VF, Stager, CE, Hansen, TN. Rapid detection of microorganisms in blood cultures of newborn infants utilizing an automated blood culture system. Pediatrics 2000;105:523–527.CrossRefGoogle ScholarPubMed
26. Singh, N, Rogers, P, Atwood, CW, Wagener, MM, Yu, VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;162:505–511.Google Scholar
27. Spain, DA. Pneumonia in the surgical patient: duration of therapy and does the organism matter? Am J Surg 2000;179:36S–40S.Google Scholar
28. Chastre, J, Fagon, JY, Trouillet, JL. Diagnosis and treatment of nosocomial pneumonia in patients in intensive care units. Clin Infect Dis 1995;21(suppl 3):S226–S237.Google Scholar
29. Maki, DG, Schuna, AA. A study of antimicrobial misuse in a university hospital. Am J Med Sci 1978;275:271–282.Google Scholar
30. Lee, KR, Leggiadro, RJ, Burch, KJ. Drug use evaluation of antibiotics in a pediatric teaching hospital. Infect Control Hosp Epidemiol 1994;15:710–712.Google Scholar
31. Dunagan, WC, Woodward, RS, Medoff, G, Gray, JL, Casabar, E, Lawrenz, C, et al. Antibiotic misuse in two clinical situations: positive blood culture and administration of aminoglycosides. Rev Infect Dis 1991;13:405–412.CrossRefGoogle ScholarPubMed
32. Pestotnik, SL, Classen, DC, Evans, RS, Burke, JP. Implementing antibiotic practice guidelines through computer-assisted decision support clinical and financial outcomes. Ann Intern Med 1996;124:884–890.Google Scholar